Showing results (251-260 of 7,117) with videos related to

Sort By:
Pageof 712
Drugs|November 26, 2019
Correction to: Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of InfluenzaYvette N Lamb
Drugs|November 28, 2019
Correction to: Dapagliflozin: A Review in Type 2 DiabetesSohita Dhillon
Drugs|February 21, 2020
TSLP Inhibitors for Asthma: Current Status and Future ProspectsMaria Gabriella Matera, Paola Rogliani, Luigino Calzetta, et al.
Drugs|February 6, 2020
The Rise and Fall "ing" of the HDL HypothesisJulien J Feghaly, Arshag D Mooradian
Drugs|January 24, 2020
Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic AgentGeorge G Zhanel, Jenine Esquivel, Sheryl Zelenitsky, et al.
Drugs|January 1, 1987
Summary of early clinical experience with anisoylated plasminogen streptokinase activator complex in the treatment of acute myocardial infarctionD Jackson
Drugs|January 1, 1987
Achievement of coronary artery patency by use of anisoylated plasminogen streptokinase activator complex in acute myocardial infarctionW S Hillis, R S Hornung, K J Hogg, et al.
Drugs|January 1, 1987
Anisoylated plasminogen streptokinase activator complex versus streptokinase in acute myocardial infarction. Preliminary results of a randomised studyP Monnier, U Sigwart, A Vincent, et al.
Drugs|January 1, 1987
Intracoronary streptokinase versus intravenous anisoylated plasminogen streptokinase activator complex in the treatment of acute myocardial infarctionL Kaspar, R Karnik, E Sehnal, et al.
Drugs|January 1, 1987
Electrocardiographic and enzymatic infarct size in a randomised study of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarctionR A Hackworthy, S G Sorensen, R L Menlove, et al.
Pageof 712